• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特发性膀胱过度活动症患者膀胱逼尿肌内注射A型肉毒杆菌毒素反应的预测因素

Predictors of response to intradetrusor botulinum toxin-A injections in patients with idiopathic overactive bladder.

作者信息

Cohen Brian L, Caruso Daniel J, Kanagarajah Prashanth, Gousse Angelo E

机构信息

Department of Urology, University of Miami Miller School of Medicine, Miami, FL 33101, USA.

出版信息

Adv Urol. 2009;2009:328364. doi: 10.1155/2009/328364. Epub 2009 Sep 8.

DOI:10.1155/2009/328364
PMID:19746201
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2739422/
Abstract

OBJECTIVES

To evaluate whether there are any demographic or urodynamic differences in patients with idiopathic overactive bladder (I-OAB) that respond and do not respond to intradetrusor injections of botulinum toxin-A (BTX-A).

METHODS

This represents a secondary analysis of data collected from an investigator initiated randomized trial designed to evaluate clinical differences in outcomes for 100 versus 150 U BTX-A in patients with I-OAB. Preinjection demographic and urodynamic data were collected. Patients were evaluated 12 weeks after injection and were determined to be responders or nonresponders as defined by our criteria. Statistical comparisons were made between groups.

RESULTS

In patients with overactive bladder without incontinence (OAB-Dry), there were no variables that could be used to predict response to BTX-A. On univariate analysis, younger patients with overactive bladder with incontinence (OAB-Wet) were more likely to respond to BTX-A than older patients. However, this relationship was no longer statistically significant on multivariate analysis.

CONCLUSIONS

We were unable to identify any preinjection demographic or urodynamic parameters that could aid in predicting which patients will achieve clinical response to BTX-A. Future studies are necessary to further evaluate this question.

摘要

目的

评估特发性膀胱过度活动症(I-OAB)患者中,对膀胱逼尿肌注射A型肉毒毒素(BTX-A)有反应和无反应的患者在人口统计学或尿动力学方面是否存在差异。

方法

这是一项对数据的二次分析,数据来自一项由研究者发起的随机试验,该试验旨在评估I-OAB患者接受100单位与150单位BTX-A治疗后临床结局的差异。收集注射前的人口统计学和尿动力学数据。在注射12周后对患者进行评估,并根据我们的标准确定为有反应者或无反应者。对两组进行统计学比较。

结果

在无尿失禁的膀胱过度活动症(OAB-Dry)患者中,没有可用于预测对BTX-A反应的变量。单因素分析显示,有尿失禁的膀胱过度活动症(OAB-Wet)年轻患者比老年患者更可能对BTX-A有反应。然而,多因素分析时这种关系不再具有统计学意义。

结论

我们无法识别任何注射前的人口统计学或尿动力学参数来帮助预测哪些患者会对BTX-A产生临床反应。未来有必要进行进一步研究以评估这个问题。

相似文献

1
Predictors of response to intradetrusor botulinum toxin-A injections in patients with idiopathic overactive bladder.特发性膀胱过度活动症患者膀胱逼尿肌内注射A型肉毒杆菌毒素反应的预测因素
Adv Urol. 2009;2009:328364. doi: 10.1155/2009/328364. Epub 2009 Sep 8.
2
Management of refractory idiopathic overactive bladder: intradetrusor injection of botulinum toxin type A versus posterior tibial nerve stimulation.难治性特发性膀胱过度活动症的治疗:膀胱逼尿肌内注射A型肉毒杆菌毒素与胫后神经刺激术的比较
Can J Urol. 2017 Jun;24(3):8838-8846.
3
Preliminary results of a dose-finding study for botulinum toxin-A in patients with idiopathic overactive bladder: 100 versus 150 units.肉毒杆菌毒素A治疗特发性膀胱过度活动症剂量探索性研究的初步结果:100单位与150单位对比
Neurourol Urodyn. 2009;28(3):205-8. doi: 10.1002/nau.20611.
4
Botulinum toxin injections for adults with overactive bladder syndrome.肉毒杆菌毒素注射治疗成人膀胱过度活动症
Cochrane Database Syst Rev. 2011 Dec 7(12):CD005493. doi: 10.1002/14651858.CD005493.pub3.
5
Preoperative urodynamic factors predicting outcome of botulinum toxin-A intradetrusor injection in children with neurogenic detrusor overactivity.预测神经源性逼尿肌过度活动患儿膀胱内注射A型肉毒杆菌毒素疗效的术前尿动力学因素
Urology. 2014 Dec;84(6):1480-4. doi: 10.1016/j.urology.2014.09.001.
6
Urodynamic assessment of poor responders after botulinum toxin-A treatment for overactive bladder.A型肉毒杆菌毒素治疗膀胱过度活动症后反应不佳者的尿动力学评估
Urology. 2008 Mar;71(3):455-9. doi: 10.1016/j.urology.2007.11.039.
7
Clinical outcomes of intravesical injections of botulinum toxin type A in patients with refractory idiopathic overactive bladder.A型肉毒毒素膀胱内注射治疗难治性特发性逼尿肌过度活动症的临床疗效。
Pharmacol Rep. 2018 Dec;70(6):1133-1138. doi: 10.1016/j.pharep.2018.08.002. Epub 2018 Aug 2.
8
Assessment of Anticholinergic Use After Fading of BTX-A Effects in Refractory Idiopathic Overactive Bladder: A Prospective Blinded Randomized Trial.肉毒杆菌毒素A(BTX-A)治疗难治性特发性膀胱过度活动症效果消退后抗胆碱能药物使用情况的评估:一项前瞻性双盲随机试验
Int Neurourol J. 2019 Sep;23(3):240-248. doi: 10.5213/inj.1938098.049. Epub 2019 Sep 30.
9
Is there any Relationship Between Bladder Trabeculation and Efficacy and Safety of Intravesical Botulinum Toxin A Injection in Refractory Idiopathic Overactive Bladder Women?膀胱小梁形成与难治性特发性膀胱过度活动症女性膀胱内注射A型肉毒杆菌毒素的疗效及安全性之间是否存在关联?
Adv Biomed Res. 2017 Aug 31;6:113. doi: 10.4103/abr.abr_393_14. eCollection 2017.
10
Botulinum toxin outcomes for idiopathic overactive bladder stratified by indication: lack of anticholinergic efficacy versus intolerability.基于适应证分层的特发性逼尿过度症的肉毒毒素治疗结局:抗胆碱能疗效缺乏与不耐受。
Neurourol Urodyn. 2011 Nov;30(8):1538-40. doi: 10.1002/nau.21150. Epub 2011 Aug 8.

引用本文的文献

1
Response to Treatment with Botulinum Neurotoxin A (BoNT-A) in Children and Adolescents with Neurogenic Lower Urinary Tract Dysfunction and Idiopathic Overactive Bladder: A Systematic Review and Meta-Analysis.神经原性下尿路功能障碍和特发性过度活动膀胱儿童和青少年应用肉毒杆菌神经毒素 A(BoNT-A)治疗的反应:系统评价和荟萃分析。
Toxins (Basel). 2024 Oct 15;16(10):443. doi: 10.3390/toxins16100443.
2
Delivering patient-centered care through shared decision making in overactive bladder.通过共同决策实现膀胱过度活动症的以患者为中心的护理。
Neurourol Urodyn. 2022 Apr;41(4):884-893. doi: 10.1002/nau.24915. Epub 2022 Mar 25.
3
Predicting outcomes after intradetrusor onabotulinumtoxina for non-neurogenic urgency incontinence in women.预测女性非神经源性急迫性尿失禁经尿道内注射肉毒毒素 A 后的结局。
Neurourol Urodyn. 2022 Jan;41(1):432-447. doi: 10.1002/nau.24845. Epub 2021 Dec 2.
4
Refractory urgency urinary incontinence treatment in women: impact of age on outcomes and complications.女性难治性急迫性尿失禁的治疗:年龄对结局和并发症的影响
Am J Obstet Gynecol. 2018 Jan;218(1):111.e1-111.e9. doi: 10.1016/j.ajog.2017.10.006. Epub 2017 Oct 12.
5
Characteristics Associated with Treatment Response and Satisfaction in Women Undergoing OnabotulinumtoxinA and Sacral Neuromodulation for Refractory Urgency Urinary Incontinence.与接受肉毒杆菌毒素 A 和骶神经调节治疗难治性急迫性尿失禁的女性治疗反应和满意度相关的特征。
J Urol. 2017 Oct;198(4):890-896. doi: 10.1016/j.juro.2017.04.103. Epub 2017 May 10.
6
Effectiveness of BTX-A and neuromodulation in treating OAB with or without detrusor overactivity: a systematic review.A型肉毒毒素与神经调节治疗伴或不伴逼尿肌过度活动的膀胱过度活动症的有效性:一项系统评价
Int Urogynecol J. 2017 Jun;28(6):805-816. doi: 10.1007/s00192-016-3225-z. Epub 2017 Jan 12.
7
Botulinum toxin treatment for overactive bladder and detrusor overactivity in adults.肉毒杆菌毒素治疗成人膀胱过度活动症和逼尿肌过度活动。
World J Urol. 2012 Aug;30(4):451-6. doi: 10.1007/s00345-011-0778-9. Epub 2011 Oct 15.
8
Intravesical botulinum toxin for lower urinary tract dysfunction.膀胱内注射肉毒杆菌毒素治疗下尿路功能障碍。
F1000 Med Rep. 2010 Jan 27;2:6. doi: 10.3410/M2-6.

本文引用的文献

1
Urodynamic assessment of poor responders after botulinum toxin-A treatment for overactive bladder.A型肉毒杆菌毒素治疗膀胱过度活动症后反应不佳者的尿动力学评估
Urology. 2008 Mar;71(3):455-9. doi: 10.1016/j.urology.2007.11.039.
2
Safety and tolerability of sedation-free flexible cystoscopy for intradetrusor botulinum toxin-A injection.用于膀胱逼尿肌注射A型肉毒杆菌毒素的无镇静柔性膀胱镜检查的安全性和耐受性。
J Urol. 2007 Mar;177(3):1006-10; discussion 1010. doi: 10.1016/j.juro.2006.10.050.
3
Experience with 100 cases treated with botulinum-A toxin injections in the detrusor muscle for idiopathic overactive bladder syndrome refractory to anticholinergics.对100例抗胆碱能药物难治性特发性膀胱过度活动症患者进行肉毒杆菌A毒素膀胱逼尿肌注射治疗的经验。
J Urol. 2006 Jul;176(1):177-85. doi: 10.1016/S0022-5347(06)00590-8.
4
Predictors of success for first stage neuromodulation: motor versus sensory response.第一阶段神经调节成功的预测因素:运动反应与感觉反应
J Urol. 2006 Jun;175(6):2178-80; discussion 2180-1. doi: 10.1016/S0022-5347(06)00315-6.
5
Histologic features in the urinary bladder wall affected from neurogenic overactivity--a comparison of inflammation, oedema and fibrosis with and without injection of botulinum toxin type A.神经源性活动亢进影响下膀胱壁的组织学特征——注射与未注射A型肉毒杆菌毒素时炎症、水肿和纤维化的比较
Eur Urol. 2006 Nov;50(5):1058-64. doi: 10.1016/j.eururo.2006.01.025. Epub 2006 Feb 6.
6
The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society.下尿路功能术语标准化:国际尿控协会标准化小组委员会报告
Neurourol Urodyn. 2002;21(2):167-78. doi: 10.1002/nau.10052.
7
How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study.膀胱过度活动症的症状有多普遍,以及如何进行管理?一项基于人群的患病率研究。
BJU Int. 2001 Jun;87(9):760-6. doi: 10.1046/j.1464-410x.2001.02228.x.
8
Bladder outlet obstruction nomogram for women with lower urinary tract symptomatology.针对有下尿路症状的女性的膀胱出口梗阻列线图。
Neurourol Urodyn. 2000;19(5):553-64. doi: 10.1002/1520-6777(2000)19:5<553::aid-nau2>3.0.co;2-b.